Home4142 • TPE
add
Adimmune Corp
Nakaraang pagsara
NT$17.35
Sakop ng araw
NT$17.00 - NT$17.55
Sakop ng taon
NT$15.90 - NT$22.60
Market cap
7.47B TWD
Average na Volume
2.46M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (TWD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 475.32M | -46.49% |
Gastos sa pagpapatakbo | 146.27M | -14.74% |
Net na kita | -18.26M | -106.93% |
Net profit margin | -3.84 | -112.96% |
Kita sa bawat share | — | — |
EBITDA | -19.68M | -106.24% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (TWD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.79B | -3.29% |
Kabuuang asset | 8.38B | -2.80% |
Kabuuang sagutin | 3.53B | 18.40% |
Kabuuang equity | 4.85B | — |
Natitirang share | 421.51M | — |
Presyo para makapag-book | 1.55 | — |
Return on assets | -1.86% | — |
Return on capital | -1.94% | — |
Cash Flow
Net change in cash
| (TWD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -18.26M | -106.93% |
Cash mula sa mga operasyon | -355.08M | -17.80% |
Cash mula sa pag-invest | -173.61M | -102.13% |
Cash mula sa financing | 403.21M | 5,593.35% |
Net change in cash | -117.89M | 70.35% |
Malayang cash flow | -460.83M | -29.17% |
Tungkol
Adimmune Corporation is a Taiwanese biopharmaceutical company headquartered in Taichung. Originally founded in 1965 as Taiwan’s first vaccine laboratory, it later evolved into a modern vaccine manufacturer and contract development and manufacturing organization. The company is notable for being the only influenza vaccine manufacturer in Asia certified by both the European Union Good Manufacturing Practice and the U.S. Food and Drug Administration, and the*only human vaccine manufacturer in Taiwan operating under PIC/S GMP standards. Wikipedia
Itinatag
1965
Website
Mga Empleyado
564
